163 related articles for article (PubMed ID: 9862757)
21. Diversity of vertebrate nicotinic acetylcholine receptors.
Millar NS; Gotti C
Neuropharmacology; 2009 Jan; 56(1):237-46. PubMed ID: 18723036
[TBL] [Abstract][Full Text] [Related]
22. Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
Gotti C; Zoli M; Clementi F
Trends Pharmacol Sci; 2006 Sep; 27(9):482-91. PubMed ID: 16876883
[TBL] [Abstract][Full Text] [Related]
23. Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors.
Pakkanen JS; Nousiainen H; Yli-Kauhaluoma J; Kylänlahti I; Möykkynen T; Korpi ER; Peng JH; Lukas RJ; Ahtee L; Tuominen RK
J Neurochem; 2005 Sep; 94(5):1329-41. PubMed ID: 16000156
[TBL] [Abstract][Full Text] [Related]
24. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line.
Lukas RJ
J Neurochem; 1991 Apr; 56(4):1134-45. PubMed ID: 2002334
[TBL] [Abstract][Full Text] [Related]
25. M2 mutations of the nicotinic acetylcholine receptor increase the potency of the non-competitive inhibitor phencyclidine.
Eaton MJ; Labarca C; Eterovíc VA
J Neurosci Res; 2000 Jul; 61(1):44-51. PubMed ID: 10861798
[TBL] [Abstract][Full Text] [Related]
26. How does bupropion work as a smoking cessation aid?
Warner C; Shoaib M
Addict Biol; 2005 Sep; 10(3):219-31. PubMed ID: 16109583
[TBL] [Abstract][Full Text] [Related]
27. Effects of dichlorobenzene on acetylcholine receptors in human neuroblastoma SH-SY5Y cells.
Yan RM; Chiung YM; Pan CY; Liu JH; Liu PS
Toxicology; 2008 Nov; 253(1-3):28-35. PubMed ID: 18761391
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion.
Arias HR; Santamaría A; Ali SF
Int Rev Neurobiol; 2009; 88():223-55. PubMed ID: 19897080
[TBL] [Abstract][Full Text] [Related]
29. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
30. Mechanism-based approach to the successful prevention of cocaine inhibition of the neuronal (alpha 3 beta 4) nicotinic acetylcholine receptor.
Krivoshein AV; Hess GP
Biochemistry; 2004 Jan; 43(2):481-9. PubMed ID: 14717603
[TBL] [Abstract][Full Text] [Related]
31. Inhibiting gene expression of alpha3 nicotinic receptor in SH-SY5Y cells with the effects on APP metabolism and antioxidation in Alzheimer's disease.
Tang Z; An Y; Qi XL; Xiao Y; Shan KR; Guan ZZ
Neurochem Int; 2008 Nov; 53(5):112-7. PubMed ID: 18647633
[TBL] [Abstract][Full Text] [Related]
32. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells.
Ambrose V; Miller JH; Dickson SJ; Hampton S; Truman P; Lea RA; Fowles J
Nicotine Tob Res; 2007 Aug; 9(8):793-9. PubMed ID: 17654292
[TBL] [Abstract][Full Text] [Related]
33. [Fluorosis on expression of nicotinic acetylcholine receptors in protein and gene levels in human SH-SY5Y neuroblastoma cells].
Guan ZZ; Shan KR; Xiu J; Long YG
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jan; 39(1):26-9. PubMed ID: 15794887
[TBL] [Abstract][Full Text] [Related]
34. Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.
Reitstetter R; Lukas RJ; Gruener R
J Pharmacol Exp Ther; 1999 May; 289(2):656-60. PubMed ID: 10215636
[TBL] [Abstract][Full Text] [Related]
35. Reversing the action of noncompetitive inhibitors (MK-801 and cocaine) on a protein (nicotinic acetylcholine receptor)-mediated reaction.
Hess GP; Gameiro AM; Schoenfeld RC; Chen Y; Ulrich H; Nye JA; Sit B; Carroll FI; Ganem B
Biochemistry; 2003 May; 42(20):6106-14. PubMed ID: 12755612
[TBL] [Abstract][Full Text] [Related]
36. Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?
Arias HR
Int J Biochem Cell Biol; 2009 Nov; 41(11):2098-108. PubMed ID: 19497387
[TBL] [Abstract][Full Text] [Related]
37. Blocking of the nicotinic acetylcholine receptor ion channel by chlorpromazine, a noncompetitive inhibitor: A molecular dynamics simulation study.
Xu Y; Barrantes FJ; Shen J; Luo X; Zhu W; Chen K; Jiang H
J Phys Chem B; 2006 Oct; 110(41):20640-8. PubMed ID: 17034254
[TBL] [Abstract][Full Text] [Related]
38. Mechanism-based discovery of small molecules that prevent noncompetitive inhibition by cocaine and MK-801 mediated by two different sites on the nicotinic acetylcholine receptor.
Chen Y; Banerjee A; Hess GP
Biochemistry; 2004 Aug; 43(31):10149-56. PubMed ID: 15287742
[TBL] [Abstract][Full Text] [Related]
39. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes.
Papke RL; Sanberg PR; Shytle RD
J Pharmacol Exp Ther; 2001 May; 297(2):646-56. PubMed ID: 11303054
[TBL] [Abstract][Full Text] [Related]
40. [3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs.
Eldefrawi AT; Miller ER; Murphy DL; Eldefrawi ME
Mol Pharmacol; 1982 Jul; 22(1):72-81. PubMed ID: 6126805
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]